Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapy.
Iwai Y, Mori S, Ishikawa H, Kanematsu N, Matsumoto S, Nakaji T, Okonogi N, Kobayashi K, Wakatsuki M, Uno T, Yamada S. Iwai Y, et al. Among authors: ishikawa h. Radiol Phys Technol. 2024 Jun;17(2):504-517. doi: 10.1007/s12194-024-00808-8. Epub 2024 May 1. Radiol Phys Technol. 2024. PMID: 38691309
Long-Term Outcomes of Ocular and Visual Preservation After Carbon Ion Radiation Therapy for Choroidal Malignant Melanoma.
Aoki S, Wakatsuki M, Tsuji H, Makishima H, Ikawa H, Yamada S, Inoue Y, Goto H, Suzuki S, Kubota T, Ishikawa H, Mizota A; Working Group for Ophthalmologic Tumors. Aoki S, et al. Among authors: ishikawa h. Int J Radiat Oncol Biol Phys. 2024 Oct 16:S0360-3016(24)03475-8. doi: 10.1016/j.ijrobp.2024.10.008. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39424082 Free article.
Significant Effect of Carbon-Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High-Risk Prostate Cancer Patients: A Two-Center Controlled Trial Compare With X-Ray External Beam Radiation Therapy.
Zhao X, Sakamoto S, Ishikawa H, Yamada Y, Aoki S, Nakajima M, Sato K, Kobayashi K, Saito S, Wakatsuki M, Ichikawa T. Zhao X, et al. Among authors: ishikawa h. Prostate. 2024 Nov 3. doi: 10.1002/pros.24818. Online ahead of print. Prostate. 2024. PMID: 39488848
Carbon-ion radiotherapy for clear cell odontogenic carcinomas.
Ikawa H, Koto M, Fugo K, Takiyama H, Isozaki T, Shinoto M, Yamada S, Ishikawa H. Ikawa H, et al. Among authors: ishikawa h. World J Surg Oncol. 2024 Jul 25;22(1):191. doi: 10.1186/s12957-024-03470-x. World J Surg Oncol. 2024. PMID: 39054550 Free PMC article.
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702".
Kawamura H, Kubo N, Sato H, Mizukami T, Katoh H, Ishikawa H, Ohno T, Matsui H, Ito K, Suzuki K, Nakano T; Group for Genitourinary Tumors at Gunma University Heavy Ion Medical Center. Kawamura H, et al. Among authors: ishikawa h. BMC Cancer. 2020 Jan 30;20(1):75. doi: 10.1186/s12885-020-6570-8. BMC Cancer. 2020. PMID: 32000716 Free PMC article.
Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study.
Ogawa K, Ishikawa H, Toyozumi T, Noma K, Kono K, Hojo H, Tamamura H, Azami Y, Ishida T, Nabeya Y, Iwata H, Araya M, Tokumaru S, Maruo K, Oda T, Matsubara H. Ogawa K, et al. Among authors: ishikawa h. Esophagus. 2024 Oct;21(4):484-494. doi: 10.1007/s10388-024-01068-6. Epub 2024 Jun 6. Esophagus. 2024. PMID: 38844703
Correction: Comparison of proton-based Definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study.
Ogawa K, Ishikawa H, Toyozumi T, Noma K, Kono K, Hojo H, Tamamura H, Azami Y, Ishida T, Nabeya Y, Iwata H, Araya M, Tokumaru S, Maruo K, Oda T, Matsubara H. Ogawa K, et al. Among authors: ishikawa h. Esophagus. 2024 Oct;21(4):495. doi: 10.1007/s10388-024-01071-x. Esophagus. 2024. PMID: 39052159 No abstract available.
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, Kodama Y, Dobashi H, Tanaka Y, Masamune A, Moriyama M, Saeki T, Matsui S, Origuchi T, Masaki Y, Asada M, Umehara H, Seno H, Naitoh I, Yamamoto S, Iwasaki E, Kubota K, Tanoue S, Nishino T, Tsuboi H, Matsumoto Y, Isayama H, Goto H, Notohara K, Uchida K, Kawabe K, Yamada K, Kasashima S, Takahira M, Sato Y, Kawachi I, Yamaguchi I, Okazaki K, Nakamura S, Matsuda F, Ishikawa H, Kawano M; Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan; *Other than the co-authors, the members of Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan are as follows: Kensuke Yokoyama (Jichi Medical University);. Yamamoto M, et al. Among authors: ishikawa h. Immunol Med. 2024 Nov 28:1-11. doi: 10.1080/25785826.2024.2430812. Online ahead of print. Immunol Med. 2024. PMID: 39607031
4,521 results